Stock Information
Autolus Therapeutics PLC (AUTL)
Ticker Symbol: AUTL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $455.10 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.8446
Revenue (TTM): $0.19 M
Dividend Yield: N/A%
ROE: -63.76%
Latest News
-
Mizuho Maintains Outperform on Autolus Therapeutics, Lowers Price Target to $10
Tue, Mar 31, 2026 9:45 AM
-
Autolus Therapeutics: Q4 Earnings Highlight Importance Of Autoimmune Data Catalysts
Fri, Mar 27, 2026 2:56 PM
-
Autolus Therapeutics plc (AUTL) Q4 2025 Earnings Call Transcript
Fri, Mar 27, 2026 2:25 PM
-
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Fri, Mar 27, 2026 12:21 PM
-
Autolus Therapeutics plc 2025 Q4 - Results - Earnings Call Presentation
Fri, Mar 27, 2026 10:26 AM
-
Earnings Scheduled For March 27, 2026
Fri, Mar 27, 2026 7:11 AM
-
Autolus Therapeutics Q4 EPS $(0.34) Misses $(0.24) Estimate, Sales $24.289M Miss $24.481M Estimate
Fri, Mar 27, 2026 7:01 AM
Key Financials
Financial data not available
